TANG CAPITAL MANAGEMENT LLC — 13F Holdings & Portfolio
CIK 1232621 · latest 13F-HR filed 2026-08-14
TANG CAPITAL MANAGEMENT LLC manages $2.20B in 13F-reported U.S. long-equity assets across 41 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AUPH (10.05%), SYRE (7.63%), MIRM (6.57%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 5 new positions, exited 15, added to 19, and trimmed 11.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 210
SAN DIEGO, CA 92121
$2.20B
Long-equity book
41
Distinct positions
2026-06-30
Filed 2026-08-14
+5 / −15 / ↑19 / ↓11
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- SPYRE THERAPEUTICS INC$72.5M +76.0%
- CORCEPT THERAPEUTICS INC$70.0M +115.7%
- COMPASS PATHWAYS PLC$48.6M +219.7%
- AURINIA PHARMACEUTICALS INC$40.1M +22.1%
- KINIKSA PHARMACEUTICALS INTL$35.7M +32.8%
Top Trims
- COMPASS THERAPEUTICS INC-$49.4M -55.6%
- INSMED INC-$31.9M -74.9%
- STATE STR SPDR S&P 500 ETF T-$17.4M -15.9%
- STOKE THERAPEUTICS INC-$6.5M -39.7%
- ATEA PHARMACEUTICALS INC-$3.5M -13.6%
New Positions
- NUVECTIS PHARMA INC$28.5M
- FULCRUM THERAPEUTICS INC$23.9M
- NANO DIMENSION LTD$20.7M
- GOSSAMER BIO INC$11.5M
- BOUNDLESS BIO INC$6.4M
Exited Positions
- KALVISTA PHARMACEUTICALS INC$92.1M
- JANUX THERAPEUTICS INC$7.0M
- BIOGEN INC$6.4M
- UROGEN PHARMA LTD$6.3M
- ARVINAS INC$5.7M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | AURINIA PHARMACEUTICALS INC | AUPH | 05156V102 | $221.4M | 10.05% | 13,044,106 | SH |
| 2 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $168.0M | 7.63% | 1,892,200 | SH |
| 3 | MIRUM PHARMACEUTICALS INC | MIRM | 604749101 | $144.7M | 6.57% | 1,236,027 | SH |
| 4 | KINIKSA PHARMACEUTICALS INTL | KNSA | G52694109 | $144.5M | 6.56% | 2,259,889 | SH |
| 5 | CELCUITY INC | CELC | 15102K100 | $137.5M | 6.25% | 1,314,594 | SH |
| 6 | CORCEPT THERAPEUTICS INC | CORT | 218352102 | $130.4M | 5.92% | 1,500,000 | SH |
| 7 | PTC THERAPEUTICS INC | PTCT | 69366J200 | $122.4M | 5.56% | 1,500,000 | SH |
| 8 | LAKEFRONT BIOTHERAPEUTICS NV | LKFT | 36315X101 | $113.5M | 5.16% | 3,785,991 | SH |
| 9 | CAPRICOR THERAPEUTICS INC | CAPR | 14070B309 | $98.7M | 4.48% | 4,099,900 | SH |
| 10 | TARSUS PHARMACEUTICALS INC | TARS | 87650L103 | $98.7M | 4.48% | 1,568,266 | SH |
| 11 | STATE STR SPDR S&P 500 ETF T | SPY | 78462F103 | $91.9M | 4.17% | 123,000 | SH |
| 12 | ANAPTYSBIO INC | ANAB | 032724106 | $89.8M | 4.08% | 1,330,879 | SH |
| 13 | IMMUNOCORE HLDGS PLC | IMCR | 45258D105 | $84.1M | 3.82% | 2,649,368 | SH |
| 14 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | $70.8M | 3.21% | 5,000,000 | SH |
| 15 | ANI PHARMACEUTICALS INC | ANIP | 00182C103 | $58.6M | 2.66% | 707,500 | SH |
| 16 | BIONTECH SE | BNTX | 09075V102 | $43.7M | 1.99% | 470,000 | SH |
| 17 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $39.4M | 1.79% | 17,990,782 | SH |
| 18 | PRECIGEN INC | PGEN | 74017N105 | $36.6M | 1.66% | 6,417,500 | SH |
| 19 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $32.9M | 1.50% | 1,792,626 | SH |
| 20 | NUVECTIS PHARMA INC | NVCT | 67080T108 | $28.5M | 1.29% | 1,550,000 | SH |
| 21 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $25.8M | 1.17% | 264,692 | SH |
| 22 | FULCRUM THERAPEUTICS INC | FULC | 359616109 | $23.9M | 1.08% | 6,521,412 | SH |
| 23 | ATEA PHARMACEUTICALS INC | AVIR | 04683R106 | $22.4M | 1.02% | 4,814,700 | SH |
| 24 | CRESCENT BIOPHARMA INC. | CBIO | G2545C104 | $20.9M | 0.95% | 1,160,000 | SH |
| 25 | NANO DIMENSION LTD | NNDM | 63008G203 | $20.7M | 0.94% | 14,292,813 | SH |
| 26 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $19.5M | 0.89% | 500,000 | SH |
| 27 | NUVATION BIO INC | NUVB | 67080N101 | $18.7M | 0.85% | 3,299,557 | SH |
| 28 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $16.8M | 0.76% | 450,000 | SH |
| 29 | GOSSAMER BIO INC | — | 38341PAA0 | $11.5M | 0.52% | 17,841,000 | PRN |
| 30 | JOURNEY MED CORP | DERM | 48115J109 | $11.4M | 0.52% | 1,610,000 | SH |
| 31 | INSMED INC | INSM | 457669307 | $10.7M | 0.48% | 100,000 | SH |
| 32 | STOKE THERAPEUTICS INC | STOK | 86150R107 | $9.8M | 0.45% | 300,000 | SH |
| 33 | PLIANT THERAPEUTICS INC | PLRX | 729139105 | $7.0M | 0.32% | 6,141,261 | SH |
| 34 | BOUNDLESS BIO INC | BOLD | 10170A100 | $6.4M | 0.29% | 2,559,875 | SH |
| 35 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $5.7M | 0.26% | 4,245,085 | SH |
| 36 | MODERNA INC | MRNA | 60770K107 | $3.5M | 0.16% | 50,000 | SH |
| 37 | WAVE LIFE SCIENCES LTD | WVE | Y95308105 | $3.5M | 0.16% | 600,000 | SH |
| 38 | HERON THERAPEUTICS INC | HRTX | 427746102 | $2.7M | 0.12% | 6,250,000 | SH |
| 39 | LENZ THERAPEUTICS INC | LENZ | 52635N103 | $2.6M | 0.12% | 451,114 | SH |
| 40 | ALTIMMUNE INC | ALT | 02155H200 | $2.0M | 0.09% | 666,022 | SH |
| 41 | ROCKET PHARMACEUTICALS INC | RCKT | 77313F106 | $342.0K | 0.02% | 100,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $2.20B | 41 | 0001214659-26-010416 |
| 2026-03-31 | 2026-05-15 | $1.97B | 51 | 0001214659-26-006493 |
| 2025-12-31 | 2026-02-17 | $2.02B | 75 | 0001214659-26-002015 |
| 2025-09-30 | 2025-11-14 | $2.60B | 194 | 0001214659-25-016677 |